MYCLERA Trademark

Trademark Overview

On Thursday, May 26, 2022, a trademark application was filed for MYCLERA with the United States Patent and Trademark Office. The USPTO has given the MYCLERA trademark a serial number of 97431092. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Empire Pharmaceutical Inc.. The MYCLERA trademark is filed in the Pharmaceutical Products category with the following description:

Topical gel for the medical treatment of viral and bacterial infections, namely, to treat cold sores in humans
myclera

General Information

Serial Number97431092
Word MarkMYCLERA
Filing DateThursday, May 26, 2022
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7414757
Registration DateTuesday, June 11, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 4, "UNITED STATES" should be deleted, and "CANADA" should be inserted. 
Goods and ServicesTopical gel for the medical treatment of viral and bacterial infections, namely, to treat cold sores in humans
Pseudo MarkMY CLERA
Certificate of Correction for RegistrationIn the statement, line 4, "UNITED STATES" should be deleted, and "CANADA" should be inserted. 

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2022
Primary Code005
First Use Anywhere DateFriday, March 8, 2024
First Use In Commerce DateFriday, March 8, 2024

Trademark Owner History

Party NameEmpire Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M4S3H7
CA
Party NameEmpire Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M4S3H7
CA
Party NameEmpire Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M4S3H7
CA

Trademark Events

Event DateEvent Description
Saturday, April 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 19, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, January 16, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, June 18, 2024TEAS SECTION 7 REQUEST RECEIVED
Tuesday, April 29, 2025TEAS SECTION 7 REQUEST RECEIVED
Thursday, August 17, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, October 4, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 27, 2023NON-FINAL ACTION WRITTEN
Friday, June 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 14, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, April 30, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Monday, May 30, 2022NEW APPLICATION ENTERED
Thursday, June 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024USE AMENDMENT FILED
Tuesday, November 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 6, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Monday, March 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 29, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, May 20, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

myclera treat cold sores humans namely infections medical treatment viral bacterial